Latest Covid-19 News | Top Covid-19 News Headlines Today | Today India news | Breaking Covid-19 News Today | English Covid-19 News Headlines - TheDailyGuardian

Centre Announces Dates for Population Census, Two-Phase Exercise from 2026

June 16, 2025, 2:22 pm

The Central government on Monday published a gazette notification announcing the initiation of the 2027 caste based census. This will be India’s 16th census since independence. The population census will be carried out in two phases and will be the first full-fledged census in the country after a 16-year hiatus after 2011.

Based on the notification, the mega enumeration activity will start from October 1, 2026, in snow-laden states like Ladakh and the hilly areas of Jammu & Kashmir, Himachal Pradesh, and Uttarakhand. The remaining India will witness the census rollout from March 1, 2027.

Notification for #Census2027 has been issued. With this, process of Census has commenced.

Reference Date: 1st March 2027 for all States/UTs except for Ladakh and snow-bound areas of J&K, Himachal Pradesh & Uttarakhand where it’ll be 1st October 2026@HMOIndia @PIBHomeAffairs pic.twitter.com/3WOWqSB9nb

— Census India 2027 (@CensusIndia2027) June 16, 2025

“The reference date for the said census shall be 00.00 hours of the 1st day of March, 2027, except for the Union territory of Ladakh and snow-bound non-synchronous areas of the Union territory of Jammu and Kashmir and the States of Himachal Pradesh and Uttarakhand,” stated the official release.

Census After a 16-Year Gap

The previous country-wide census was held in 2011. As a result of delays due to the COVID-19 pandemic and other procedural challenges, the 2021 exercise that was planned was put off. The census of 2027 plans to fill the 16-year gap using advanced technology and digitalised procedures.

The Centre announced that the operation will have about 34 lakh enumerators and supervisors backed by 1.3 lakh trained functionaries who will have digital equipment. The census will be completely digital this time, with higher standards of data security during collection, transmission, and storage.

Two-Phase Enumeration: HLO and PE

The exercise will be carried out in two phases:

Houselisting Operation (HLO): Government officials will collect information on dwelling conditions, facilities, and assets of every household.

Population Enumeration (PE): It will document demographic, socio-economic, and cultural data of every individual.

Self-Enumeration to Empower Citizens

The government will also provide citizens with the opportunity to engage in the census via a self-enumeration portal that has been created by the Office of the Registrar General of India (ORGI). Moreover, the Self-Enumeration (SE) web portal allows users to conveniently input and update data for household members online.

The portal will authenticate users through a one-time password (OTP) sent to registered mobile numbers. Respondents can add new members, edit details, and mark persons who have shifted or expired.

Though the BJP-led government had previously censured calls for caste enumeration by the opposition, it did a turnaround this year by declaring a census of castes. Consequently, political pundits consider the development a game-changer ahead of future elections, especially given the increasing emphasis on social justice and representation.

India Reports 6 Covid-19 Deaths in a Day; Active Cases Climb to 7,121

June 11, 2025, 11:39 am

India’s active Covid-19 cases have climbed to 7,121 after 306 new infections were reported in the last 24 hours, according to data released by the Ministry of Health and Family Welfare on Wednesday. During the same period, six more people lost their lives due to the virus.

Among the six fatalities, three were from Kerala, two from Karnataka, and one from Maharashtra. One of the victims was a 43-year-old man with a weakened immune system. The others were older people individuals who had chronic and respiratory conditions, making them more vulnerable.

New Variants Fueling the Surge

The recent increase in Covid-19 cases is linked to emerging virus variants. These include LF.7, XFG, JN.1, and the newly detected NB.1.8.1 subvariant. These strains are contributing to the current spike in infections across several parts of the country.

State-Wise Covid-19 Breakdown

Kerala remains the worst-hit state, with 2,223 active cases. It also recorded the highest number of new infections in the past 24 hours at 170. Gujarat came next with 114 fresh cases, raising its active count to 1,223. Delhi saw a rise as well, reporting 66 new cases and 757 active ones overall.

Here’s a quick snapshot of major states:

State	Active Cases	New Cases (Last 24 Hours)	Deaths (Last 24 Hours)
Kerala	2,223	+170	3
Maharashtra	615	+2	1
Gujarat	1,223	+114	0
Delhi	757	+66	0
West Bengal	747
Karnataka	459	-100	2
Tamil Nadu	204	-3	0

Experts Call for Targeted Protection, Not Mass Boosters

Medical experts are advising against launching another mass booster vaccination drive. Instead, they recommend prioritizing high-risk individuals—particularly the older people with chronic diseases, and those with compromised immune systems.

Experts pointed out that most people now have some level of hybrid immunity due to prior infections and vaccination. Hence, extra booster doses are not required for the general population at this time.

“Widespread hybrid immunity makes mass boosters unnecessary,” health experts noted. However, they emphasized the continued importance of Covid-appropriate behavior such as wearing masks, hand hygiene, and avoiding crowded spaces.

Government Advisories and Preventive Measures

In response to the rising number of cases, the central government has issued fresh advisories to all states and union territories. These guidelines emphasize staying alert and prepared for any potential surge.

Doctors have urged people to be cautious and differentiate between Covid-19 and other common seasonal illnesses that cause similar symptoms like fever, tiredness, and respiratory issues.

Vulnerable groups—especially older adults and those with pre-existing medical problems—are being advised to seek medical help promptly if symptoms arise or worsen.

The Indian Medical Association (IMA) also echoed this sentiment, urging everyone to follow preventive steps like wearing masks and maintaining personal hygiene to prevent further spread.

Delhi sees fresh surge in Covid-19 cases

June 8, 2025, 2:06 am

Delhi faces rising Covid-19 cases driven by new Omicron sub-variants, prompting enhanced health measures.

New Delhi: The national capital is experiencing a renewed spike in Covid-19 cases, with the count surpassing the 500-mark. Out of the 5,364 active cases recorded in India till Friday, June 6, 2025, Delhi holds the fourth-highest tally with 592 cases, following Kerala (1,679), Gujarat (615), and West Bengal (596). On average, Delhi is conducting around 1,200 RT-PCR tests daily.

Since May 22, the country has witnessed a steep increase in active cases, rising from 257 to more than 5,000. Kerala continues to be the worst-hit state, followed closely by Gujarat, West Bengal, Delhi, and Maharashtra, as per the latest data released by the Ministry of Health and Family Welfare.

According to updates on the Union Health Ministry’s official dashboard, Delhi has recorded seven Covid-related deaths since January 2025. Earlier this week, a 22-year-old female patient, who was already battling pulmonary tuberculosis and bilateral lower respiratory tract infection, succumbed to the virus. In addition, two other Covid-positive patients also passed away: one was a 60-year-old woman suffering from acute intestinal obstruction following laparotomy, and the other was a 71-year-old man diagnosed with pneumonia, septic shock, and acute kidney injury.

The recent surge in Covid-19 cases in India and other Southeast Asian countries has been attributed to the growing presence of Omicron-related sub-variants. Health officials in several countries have confirmed the spread of JN.1 variant sub-lineages such as LF.7 and NB1.8. The N.1 sub-variant is a descendant of BA.2.86 and is part of the Omicron family, known for its high transmission potential.

In response to the increase in cases, the central government has issued advisories to all states and union territories, urging them to ensure the availability of essential medical supplies, including oxygen and life-saving medications. Health experts emphasise the importance of distinguishing between Covid-19 and other viral fevers, as both share similar symptoms such as fever and fatigue.

To gain further insights into the current wave of infections, The Sunday Guardian spoke with Dr Neetu Jain, Senior Consultant of Pulmonology, Critical Care, and Sleep Medicine at PSRI Hospital. Dr Jain noted that the new variant appears to be significantly more transmissible than previous strains, which increases the speed of its spread. However, early indicators suggest that it may not lead to more severe illness in most patients. Nevertheless, individuals with compromised immune systems, elderly citizens, and those with underlying health conditions remain at greater risk. Ongoing surveillance and data analysis are underway to fully understand the variant’s impact. Dr Jain further explained that this strain has undergone genetic mutations, making it more adept at spreading and possibly evading some of the immunity developed from past infections or vaccinations. Despite these changes, current vaccines continue to provide strong protection against severe outcomes. The symptoms of this variant may vary slightly or overlap with those of other strains. Additionally, she emphasised that Delhi has strengthened its Covid-19 response through increased surveillance, expanded testing, and improved hospital readiness. Healthcare workers have received updated training, and public health advisories are being circulated. The city is also intensifying its vaccination and booster dose campaigns. Though the situation remains challenging, authorities are adopting proactive measures to manage any future escalation in cases. She urged individuals to persist in wearing masks in crowded or enclosed settings, maintain proper hand hygiene, avoid unnecessary gatherings, and keep their vaccinations up to date. Monitoring for symptoms and seeking prompt medical care is essential. She also advised residents to follow government advisories and stay informed through credible updates.

India Crosses 1,000 Active Covid Cases After 3 Years, Kerala Leads With 40% Infections

May 27, 2025, 1:07 pm

India had 1,010 active COVID-19 cases on May 26, the first time in almost three years that active cases had surpassed 1,000. The recent increase has generated fear about the spread of the virus, with cases cropping up in states that previously reported zero cases. Punjab, for example, confirmed its first case of the ongoing wave on May 26.

Kerala, Maharashtra, Delhi Account for Bulk of Cases of Covid

Three large states—Kerala, Maharashtra, and Delhi—cover almost 74 percent of India’s active COVID-19 cases. Kerala heads the list with more than 40 percent of all infections across the country. Maharashtra has 210 active cases, while Delhi has reported 104.

India has seen six Covid fatalities since May 19—three in Maharashtra, two in Kerala, and one in Karnataka.

Vaccination Gaps Persist Across Age Groups

Despite India’s extensive vaccination coverage, gaps in precautionary dose coverage are still large. An MC analysis shows that just 25 percent of eligible adults have taken the precautionary or booster dose. The data also shows that second-dose coverage is not complete, with just 93 percent of first-dose recipients completing their second dose.

Younger populations also have lower rates of vaccination. Just 78.8 percent of the 12–14 age group has received their second dose, less than the 86.6 percent rate for the 15–18 population and 93.9 percent for adults 18 and older.

Northeastern States Have Low Booster Coverage on Covid

Five states still have precautionary dose coverage under 10 percent, which is serious vulnerabilities in the event of future outbreaks. Among them, Meghalaya, Nagaland, and Punjab have fewer than 9 percent of their eligible population boosted.

The case rise, with sluggish booster uptake, highlights the need for fresh awareness and booster vaccination drives to avert another outbreak at large scale.

US Faces Ongoing Toll of 300 Weekly COVID-19 Deaths—What You Need to Know

May 26, 2025, 9:04 pm

As cases of COVID-19 spread through South Asia, the United States persists in reporting hundreds of weekly virus-related deaths. The Centers for Disease Control and Prevention (CDC) reports that COVID-19 resulted in a weekly average of 350 deaths during last month, generating concern about vulnerable populations.

Dr. Tony Moody, a professor in Duke University Medical Center’s division of infectious diseases, described the situation in a statement to ABC News. “The fact that we’re still having deaths just means it’s still around, and people are still getting it,” he said, attributing the situation to the continued existence of the virus.

New Variant Spotted in US Airports, NB.1.8.1 variant reaches through global travelers. CDC officials have reported the detection of a new COVID-19 variant—NB.1.8.1—at US airports. The variant has been linked to a steep spike in infections in China. As part of its airport screening program, the CDC found the variant in travelers who entered Washington state, California, Virginia, and the New York City region, CBS News reported.

Origin of the Variant and Spread Across States

Cases associated with several countries and US states

Most cases of the NB.1.8.1 variant are attributed to individuals traveling from countries such as China, Japan, South Korea, France, among others, based on information from the Global Initiative on Sharing All Influenza Data (GISAID). These cases were confirmed between April 22 and May 12.

Apart from cases found at airports, CBS News also covered the occurrence of the NB.1.8.1 variant in various US states such as Ohio, Rhode Island, and Hawaii. These cases seem to be unrelated to cases reported through airport checks.

Progress Made but Risk Remains

Deaths Have Decreased but Not Eradicated

Although 350 weekly deaths is a big number, the CDC was quick to observe that it is down from the past months. To put this into perspective, the record weekly death count was 25,974 for the week that ended January 9, 2021. Though there has been considerable improvement in the last few years, the disease still has a threat, especially to members of high-risk categories.

Reasons for Continuing Death Toll

Experts cite a number of reasons behind the continuing deaths. These include waning immunity, reduced access to treatment, and low or stagnant vaccination levels. These could be among the reasons why the virus is still claiming lives in America even while its threat appears to be receding around the world.

COVID Cases Rise in India as Two New Variants NB.1.8.1 and LF.7 Detected

May 26, 2025, 3:04 pm

India registered an upsurge in Covid-19 cases as it also identified two new subvariants of SARS-CoV-2, namely NB.1.8.1 and LF.7. The health ministry validated the upsurge with Kerala at the forefront of new infections. Experts highlight that these variants are at the moment being monitored and not considered variants of concern.

The government is in high alert as states are reporting growing numbers of cases, although most are mild.

Covid-19 Cases Surge, Kerala Tops

Kerala had 430 new Covid-19 cases during the last week, the highest in Indian states. Maharashtra and Delhi had 209 and 104 cases, respectively. Tamil Nadu, Karnataka, Gujarat, West Bengal, Rajasthan, and Uttar Pradesh also had new infections.

All in all, India has 1,009 active cases now. Even with the surge, authorities say that most of the cases are mild and are treated at home.

Novel Variants INSACOG’s discovery

India’s SARS-CoV-2 Genomics Consortium (INSACOG) has identified two new subvariants, NB.1.8.1 and LF.7. The World Health Organization (WHO) has categorized both as “Variants Under Monitoring.” This suggests that they do not pose a serious threat to global health at this time. Nevertheless, the spread of both is being closely monitored by authorities to determine whether transmissibility or severity changes.

The Union Health Secretary had a meeting on Saturday with top officials from the Indian Council of Medical Research (ICMR), the Department of Health Research (DHR), the Directorate General of Health Services (DGHS), and the National Centre for Disease Control (NCDC).

They discussed the new variations and the recent surge. High-level coordination is required to plan a timely and efficient response.

Precautions and Public Guidance

Experts highlight that these variants are at the moment being monitored and not considered variants of concern. The government is in high alert as states are reporting growing numbers of cases, although most are mild.

How Strong Are the New Covid Strains? Should You Be Worried?

May 24, 2025, 10:43 pm

Fresh Covid-19 cases in major cities like Mumbai, Chennai, Bengaluru, Delhi, and Ahmedabad are reviving anxieties across India. After Hong Kong and Singapore experienced surges, seeing infections in high-risk groups such as infants in Karnataka has caused public health worries. Yet, doctors did not admit any of the infants to intensive care, which brings some comfort.

While that is happening, the Delhi government has also issued an advisory asking hospitals to prepare with sufficient beds, oxygen, medicines, and vaccines if cases increase further.

New Variants of Covid Fuel Recent Spurt

Health specialists advised individuals, particularly the aging population, pregnant women, and those who have certain health conditions, to reinstate simple precautions, including wearing masks indoors and practicing hand hygiene. This is because SARS-CoV-2, the virus responsible for COVID-19, keeps evolving with new variants and sub-variants even though the pandemic has transitioned to its endemic stage.

Among the newer variants of COVID-19 gaining prominence is JN.1, a descendant of the Omicron BA.2.86 branch, or “Pirola.” Initially detected in the US in August 2023, JN.1 has circulated worldwide because it is highly transmissible and partially immune-evading. Health experts suspect that two of its sub-lineages, LF-7 and NB.1.5, are driving the recent surges of cases in India and Southeast Asia.

JN.1 and its sub-variants contain over 35 mutations in the spike protein — the viral component that allows it to latch onto human cells — making them more infectious. The sub-variants even transmit faster than previous Omicron variants such as XBB.1.5. Their capacity to partially escape immunity from previous infections and vaccination adds to the high numbers of cases over the past few weeks.

Understanding Variants and Immune Escape

SARS-CoV-2 also keeps changing as it propagates, and some changes provide the virus with benefits like improved infectivity or immune escape. If this happens, new sub-variants emerge and can dominate older strains. LF-7 and NB.1.5 have the main mutational characteristics of JN.1 but also possess extra mutations that may make them better immune escape or transmission agents. In April and May, these sub-variants explained more than 70% of Singaporean and Hong Kong sequenced cases.

Surprisingly, viral evolution prefers transmissibility and immune evasion to increased virulence, i.e., the new variants spread more efficiently but are not more virulent than their ancestors. The pattern is in line with most respiratory viruses evolving in highly immune populations.

Should India Worry About Covid-19?

Although this new variant of COVID-19 and its lineage are more transmissible, the specialists assure the population that these variants do not generate more severe illness. Dr. T Jacob John, a renowned virologist, clarified that these are all Omicron sub-variants producing mostly upper respiratory tract illness with little lung infection and no serious hypoxia or blood clotting complications. He likened the situation to influenza season, when there can be occasional spikes, but they are controllable.

“There is no cause for alarm yet,” said Dr. John in an interview with TOI. “The strain of the virus is mild and can be handled. No mortality is reported so far. Caution and preparedness are necessary, but there is absolutely no need to panic.”

Dr. Sunil Khaparde, a senior public health expert, seconded this opinion, pointing out the low fatality and controllable nature of the ongoing surge. Dr. Nitin Shinde, a Nagpur-based infectious disease expert, pointed to India’s natural immunity: “The natural immunity that has been developed in India is strong enough. The prevalent virus now is not leading to severe disease at all. People should not worry.”

Moving Forward: Vigilance and Preparedness

Though the virus now acts more like an endemic respiratory illness, there is a warning issued by specialists to avoid complacency. The Delhi government’s recent warning to mobilize health facilities is a pointer to the reality that there should be no let-up. The aged, pregnant women, and those with comorbidities need to keep following precautions like wearing masks in indoor areas and frequent handwashing.

Vaccination, genomics surveillance, and adaptive public health measures are still essential to the control of this dynamic virus. The recent appearance of JN.1 and its sub-lineages reminds us that SARS-CoV-2 has not disappeared — it has changed, and we must change our response too.

Rare Brain Reaction to COVID-19 Leaves 8-Year-Old in Coma, Then Dead

May 21, 2025, 4:54 pm

A tragic case in China has uncovered an unusual and lethal neurological complication of COVID-19 in kids. An eight-year-old girl sadly passed away after the virus infected her brain, leading to a condition called acute necrotising encephalopathy (ANE). The terrifying account is a stark reminder that the virus can have unpredictable and serious effects, even outside of respiratory issues.

COVID-19: Rare but Fatal Outcome

The girl first presented with typical symptoms, including fever, headaches, vomiting, and a rough rash on the arms, legs, and trunk. Despite all these symptoms, the doctors did not instantly test her for COVID-19 due to a lack of a recognizable trigger. Her health quickly deteriorated with repeated seizures and bad neurological regression. She started “frothing at the mouth,” and her limbs became stiff and shook. Doctors eventually intubated her to support breathing, but nine days after her initial symptoms manifested, she was pronounced brain dead, and life support was discontinued.

Medical examinations at Guangzhou Women and Children’s Medical Centre affirmed ANE, a condition of the brain which is not common and suspected to have been caused by infection with COVID-19. The physicians also found rotavirus in her blood and stool; however, they declared COVID-19 as a more probable cause of her neurological complications. The physicians explained in the journal BMC Infectious Diseases, “Despite aggressive therapy, the patient remained in profound coma without sedation.”

Understanding Acute Necrotising Encephalopathy

ANE is a consequence of an exaggerated immune response to a viral infection such as COVID-19 or influenza. Excessive inflammation caused by the body destroys tissues throughout, including those of the brain. Toxins and bacteria then penetrate the brain, destroying cells and producing swelling. Although extremely uncommon, with fewer than a hundred recorded instances, ANE’s quick development kills it. Physicians at the Guangzhou Medical Center point out that they are continuing to study how to most effectively treat children suffering from this accelerated neurological deterioration brought about by COVID-19.

A Warning for Vigilance

This heart-wrenching case highlights the imperative of raising awareness regarding the rare but intense neurological effects of COVID-19 among children. As the virus begins to surge again around the world, medical professionals have to be watchful for the onset of neurological stress in children at the earliest. Early diagnosis and intervention could prove lifesaving in such a situation

New COVID-19 JN.1 Variant Spreads Rapidly Across Asia: What You Need to Know

May 20, 2025, 12:29 pm

As a new wave of COVID-19 sweeps through some areas of Asia, health authorities globally are becoming more cautious. Singapore, Hong Kong, China, and Thailand have reported an uptick in new cases. The cause of the rise is mainly attributed to the transmission of new Omicron subvariants, most notably JN.1 and its derivative strains. Healthcare authorities closely monitor this developing situation to address possible risks.

COVID-19 Cases Spiking in Asia

Dailies in Singapore rose sharply to more than 14,000 early in May 2025, from a high of 11,100 in late April. Hospitalizations have also risen, though intensive care unit (ICU) cases have decreased slightly. Authorities are quick to point out that there is no present evidence yet to indicate that these variants are more contagious or cause a more severe illness compared to earlier strains.

Experts attribute the increased cases of infections, in part, to waning immunity over time in populations. Experts forecast that regular waves of COVID-19 will keep happening. Presently, the predominant variants currently going around are LF.7 and NB.1.8, both progeny of JN.1. The two variants combined account for over two-thirds of the sequenced instances.

At the same time, India has not seen any major surge in COVID-19 cases. According to the Ministry of Health and Family Welfare, there are only 93 active cases as of May 19, 2025. In Mumbai, some physicians have reported a slight increase in mild cases, mainly among the young. But health officials reiterate that there is no sign of a new wave and recommend continued caution, particularly as nearby countries are experiencing surges.

What Is the COVID-19 JN.1 Variant?

JN.1 is a lineage of the Omicron BA.2.86 variant that was first identified in August 2023. The World Health Organization (WHO) designated it as a Variant of Interest in December 2023. The variant has around 30 mutations—more than any other variant at the time—engineered to avoid the immune system. BA.2.86, however, did not emerge as the dominant strain in 2023 despite these mutations.

JN.1 originated from BA.2.86, with one or two mutations that advance its ability to transmit. It has the immune-evasion properties of its parent, but is more successful at spreading. Johns Hopkins University, a credible source of COVID-19 information, informs us that JN.1 is now the most prevalent variant of the virus in most regions of the globe.

In the 12th epidemiological week of 2025, JN.1 comprised a huge 93.9% of cases across the Western Pacific region, 85.7% in Southeast Asia, 94.7% in Europe, and 93.2% in the Americas.

Vaccine Effectiveness Against JN.1

Research indicates that JN.1 is more difficult for the immune system to fight. Vaccinated individuals or those with prior infection have fewer antibodies that can neutralise JN.1 than with previous variants, making it partially escape current immunity.

Luckily, the XBB.1.5 monovalent booster was created to protect against the XBB.1.5 Omicron subvariant aids in strengthening protection against JN.1. The WHO explains that the booster increases antibody levels and provides 19% to 49% protection against symptom occurrence due to JN.1, as per United States studies.

Multiple XBB.1.5 monovalent vaccines have been deployed globally, such as the Pfizer-BioNTech Comirnaty and Moderna Spikevax (both US, EU, Canada, Australia-approved mRNA vaccines), Novavax’s Nuvaxovid (protein subunit vaccine approved in the EU), and Zapomeran (Kostaive) of the self-amplifying mRNA vaccine approved in Japan and the EU.

In India, the Covovax XBB.1.5 monovalent booster is still the sole COVID-19 vaccine tailored specifically to address the Omicron XBB.1.5 subvariant.

Symptoms and Risks of JN.1

Symptoms due to JN.1 are very similar to those due to other variants of COVID-19. They include sore throat, fever, runny or stuffy nose, dry cough, fatigue, headache, loss of taste or smell, muscle pain, conjunctivitis, diarrhea, and vomiting. A few patients experience more severe fatigue and tiredness. Shortness of breath is still a critical symptom that needs urgent medical care.

Health authorities strongly advise individuals to remain vigilant, maintain vaccination, and pay close attention to signs as novel variants keep surfacing in the area.

How Harmful Is JN.1?

JN.1 is more contagious than previous variants of COVID-19 but does not lead to more severe disease. The majority of individuals infected with JN.1 have mild to moderate symptoms such as sore throat, fever, and cough. Severe cases are uncommon, and hospitalization has not been significantly affected.

Death rates attributed to JN.1 are still lower than in earlier waves of COVID-19, suggesting the decreased severity of the variant overall. Vaccines and boosters remain effective shields against severe illness. Thus, keeping up with vaccinations is key to minimizing risk and keeping transmission at bay.

COVID-19 Cases Surge in Hong Kong and Singapore Amid New Wave: Key Reasons

May 18, 2025, 10:51 pm

COVID-19 cases are once again surging in the financial hubs of Hong Kong and Singapore after a relatively calm period, signalling a fresh wave of infections across parts of Asia.

Health authorities attribute the rise to declining population-level immunity and lower booster shot uptake among the elderly. While the situation does not currently reflect a return to peak pandemic conditions, both cities are witnessing signs of widespread community transmission.

Spike in Singapore: Cases and Hospitalisations on the Rise

In Singapore, the Ministry of Health recorded 14,200 COVID-19 cases in the week ending May 3, a jump from 11,100 the week before. Hospital admissions also rose by around 30% over the same period.

While reduced immunity is likely a major contributing factor, Singapore’s health ministry clarified that there is currently “no indication that the circulating variants are more transmissible — or cause more severe cases — than during the pandemic.”

Two subvariants, LF.7 and NB.1.8 — both stemming from the JN.1 strain, which newer COVID-19 vaccines target — are currently circulating in the country. These updated vaccines have not yet been made available in India.

Hong Kong Reports Highest Positivity in a Year

Hong Kong has reported a steep rise in COVID-19 infections, with health officials flagging the highest respiratory sample positivity rate in a year. Albert Au, head of the Communicable Disease Branch at the Centre for Health Protection, described the situation as “quite high.”

The city registered 31 COVID-related deaths in the week ending May 3, marking a one-year high. Rising viral loads in sewage samples and an increase in COVID-related hospital visits indicate widespread transmission in the densely populated city of over 7 million.

Respiratory samples testing positive for COVID-19 increased to 13.66% in the week ending May 10, compared to 6.21% four weeks ago, as reported by Indian Express.

Indian Experts Urge Caution but Dismiss Panic

Despite the alarming rise in infections in East Asia, Indian virologists and health experts remain cautiously optimistic. Speaking to News18, they emphasised that India is unlikely to see a severe wave thanks to existing immunity levels.

“There is no cause for panic,” experts stated, noting that most people in India have strong protection against severe illness. However, they warned that mild infections mimicking cold or flu symptoms are still possible.

They advised continued adherence to basic preventive measures, especially for high-risk groups such as children, the elderly, and individuals with underlying health issues.

As global attention returns to the virus amid fresh outbreaks, health experts continue to emphasise the importance of booster shots, timely medical attention, and awareness to prevent another widespread health crisis.

Hong Kong Sees New Covid Surge : What’s Happening?

May 16, 2025, 3:04 pm

Several countries in Southeast Asia are facing a new wave of Covid-19 infections. Hong Kong and Singapore have reported sharp increases in cases, while China and Thailand are also seeing a rise. According to Bloomberg, this may be part of a larger regional trend.

Hong Kong Sees New Covid Surge

Health officials in Hong Kong say Covid infections are climbing fast, marking the start of another wave. Data from the Centre for Health Protection shows the test positivity rate jumped from 1.7% in March to 11.4%—even higher than the August 2024 peak.

In the past month, there were 81 severe adult cases, leading to 30 deaths, as reported by the South China Morning Post.

Albert Au, who heads the Communicable Disease Branch at the Centre for Health Protection, said Covid levels are currently “quite high.” He also noted that the percentage of respiratory samples testing positive for the virus is now at a one-year high.

Most severe cases are in old people. The Centre found that 83% of the serious infections involved individuals aged 65 or older, and more than 90% had pre-existing health conditions.

While the number of cases is still lower than the worst periods in recent years, other signs—like high virus levels in sewage and more hospital visits—show that Covid is spreading in Hong Kong again, Bloomberg noted.

Popular singer Eason Chan had to cancel concerts in Kaohsiung, Taiwan, after testing positive. This was announced through the event’s official Weibo page.

Singapore Also Reports Rise in Cases

Singapore, another financial hub, is also dealing with a spike in infections. The health ministry issued its first update in nearly a year after the number of weekly cases rose by 28%, reaching 14,200 in the week ending May 3. Daily hospital admissions also rose by about 30%.

Officials from the health ministry and the Communicable Diseases Agency said they are monitoring the situation closely. However, the ministry stated, “there is no indication that the variants circulating locally are more transmissible or cause more severe disease compared to previously circulating variants.”

Singapore now provides case updates only when there is a noticeable rise. Authorities believe the main cause of the surge is waning immunity, not a more dangerous version of the virus.

The two dominant variants currently spreading in Singapore are LF.7 and NB.1.8, which are linked to the JN.1 strain. Together, these account for more than two-thirds of sequenced cases.

Covid Rising in China and Thailand Too

Other Asian countries are also reporting more infections. China is seeing Covid levels rise to nearly what they were during last summer’s wave. According to China’s CDC, the number of positive test results in hospitals more than doubled between late March and early May.

In Thailand, the Disease Control Department reported two cluster outbreaks this year. Many new infections happened after April’s Songkran festival, which involves large gatherings and celebrations.

Why Are Cases Going Up? Should You Be Worried?

One reason for the rise in cases appears to be weakening immunity. Channel News Asia reports that many people are skipping booster shots, especially in Singapore.

Dr. Lim Kim Show, medical director at Life Family Clinic, told the outlet that most Covid patients visiting his clinic had not received a vaccine in the last one or two years.

Singapore’s health ministry confirmed that immunity may be dropping. However, it added there is “no sign that the current variants are spreading faster or causing more serious illness compared to those seen earlier during the pandemic.”

So, is there reason to worry? For now, doctors say the situation is manageable. According to CNA, most infected people are recovering quickly, and symptoms are mild—similar to the common flu.

Still, those at higher risk, such as the people with health issues, are advised to be cautious. Health officials in Singapore suggest getting a booster shot about one year after the previous dose.

Authorities also recommend simple safety measures like handwashing, staying home when feeling sick, and wearing masks in crowded areas—especially in places with rising cases.

Covid Makes a Return: What Hong Kong and Singapore’s Latest Data Reveals

May 16, 2025, 1:24 pm

Years since the height of the world pandemic, Covid-19 is back in the news again, this time more so in Asia’s economic giants—Singapore and Hong Kong. Recent statistics from health authorities show an alarming trend of increased infections, severe cases, and renewed strain on public health facilities.

Hong Kong Sees ‘Quite High’ Covid Activity

In Hong Kong, the virus has insidiously returned to the public sphere. Albert Au, director of the Communicable Disease Branch of the Center for Health Protection, referred to the level of current virus activity as “quite high.” He spoke with local media this week, affirming that the number of positive respiratory samples had hit its highest level in a year.

Adding to the alarm, severe cases—involving deaths—rose to 31 in the week of May 3, also a one-year high. While the ongoing surge is less virulent than the waves of 2022 and 2023, warning signs are still present. The spiking viral load in sewage samples and a spurt in medical consultations and hospitalizations indicate a fast spread.

Singapore Fights a Sudden Spike in Covid

Singapore, also, is seeing a significant surge. According to official statistics, COVID-19 cases increased 28% within a week to reach 14,200 cases through May 3. The city-state has changed to reporting only when significant surges happen—an in itself disturbing trend.

The Ministry of Health attributed the surge to waning immunity among the populace as one of its major driving factors. Nevertheless, it also assured people that the new variants are not more virulent or contagious than the earlier strains.

Regional Impact and Response

This spike is part of a wider regional pattern, and with alarms ringing now also in mainland China, warnings are being sounded. Statistics from the Chinese Centre for Disease Control and Prevention reveal a rise close to last year’s peak, and this suggests Asia may again be faced with a major Covid challenge.

Regional health authorities have called on high-risk groups to get booster shots and continue preventive measures. Asia once again faces the frontline as the war against Covid continues.

Scientists in Wuhan Lab Discover Covid-19-Like Bat Virus, Poses Risk Of Animal-to-Human Transmission

February 22, 2025, 3:02 am

Researchers at the Wuhan Institute of Virology in China have identified a new coronavirus in bats that bears similarities to the virus responsible for Covid-19, potentially posing a new risk to human health, according to Bloomberg.

Although the virus has not yet been detected in humans, scientists found that it enters cells using the same receptor as the coronavirus that caused Covid-19. The researchers explained that the virus infects cells by binding to a protein present in humans and other mammals. It is closely related to the coronavirus family responsible for Middle East respiratory syndrome (MERS).

The findings, published in Cell on Tuesday, have raised concerns about the virus’s potential to jump from animals to humans. MERS has been confirmed in approximately 2,600 people worldwide between 2012 and May 2024, with a fatality rate of around 36%. Most of these cases were reported in Saudi Arabia, according to the World Health Organization.

The Wuhan Virus Research Centre is well known for its studies on bat coronaviruses. One theory regarding the origin of the Covid-19 pandemic suggests that the virus may have leaked from the Wuhan lab, possibly through an infected worker.

Researchers at the institute have previously denied handling any viruses capable of triggering the pandemic. In 2023, the U.S. halted funding for the lab, which had received financial support through the U.S.-based EcoHealth Alliance, amid ongoing controversy.

Impact on Stock Market

The announcement immediately influenced the stock market, leading to notable gains for vaccine manufacturers. Moderna Inc. saw an increase of up to 6.6%, while Novavax Inc. rose by 7.8%. Meanwhile, American depositary receipts of BioNTech SE, Pfizer’s partner in developing the Covid vaccine, jumped 5.1%, and Pfizer experienced a 2.6% rise.

China Sees Record 20% Drop in Marriages, Raising Demographic Concerns

February 10, 2025, 7:07 pm

The marriage landscape of China is undergoing a significant shift, with a sharp decline in marriage registrations. The Ministry of Civil Affairs reported a 20% drop in marriages last year, with only 6.1 million couples tying the knot, down from 7.68 million in the previous year. This drastic decline has raised concerns among authorities actively promoting marriage and childbearing to combat the nation’s shrinking population.

Demographer Yi Fuxian from the University of Wisconsin-Madison described the drop as “unprecedented,” noting that even during the COVID-19 pandemic in 2020, the decline was only 12.2%. He also pointed out that marriage rates last year were less than half of the 13.47 million recorded in 2013.

If this trend continues, Fuxian warned that “the Chinese government’s political and economic ambitions will be ruined by its demographic Achilles’ heel.”

China’s Aging Population Poses Challenges

China, the world’s second-most populous country, is witnessing rapid aging. In the next decade, around 300 million citizens—equivalent to the entire US population—are expected to enter retirement. The birth rate has been on a steady decline for decades, largely due to the one-child policy (1980-2015) and rapid urbanization.

These factors have contributed to the population crisis, with China’s total population declining for the third consecutive year.

Government Initiatives to Boost Marriage and Childbearing

Authorities have launched various initiatives to address this demographic challenge. Last year, the government urged colleges and universities to provide “love education,” encouraging positive views on marriage, love, fertility, and family. In November, the state council directed local governments to allocate resources toward resolving the population crisis and promoting respect for marriage and childbearing “at the right age.”

Dragon Year Effect on Birth Rates

Despite efforts to boost births, the numbers remain a concern. A slight increase in births last year was observed, attributed to 2024 being the Chinese zodiac year of the dragon. Traditionally, children born in this year are believed to have great fortune and ambition, prompting some couples to plan births accordingly. However, this small surge has not reversed the overall declining trend.

Divorce filing also went up and, according to data, exceeded 2.6 million last year; as a result, this is an uptrend of 1.1% against last year’s figures of 2023. As China faces its demographics battle, authorities have to go through a hard time to convince the youths to get married, give birth, and ideally to instill family ethics among them.

CIA Assesses Lab Origin Of COVID-19 As “More Likely” Than Natural Emergence

January 26, 2025, 2:18 am

Central Intelligence Agency has determined that an incident of laboratory origin, rather than natural transmission, is more likely to be behind the COVID-19 outbreak, a spokesman said on Saturday.

For years, the CIA told the world that it could not say definitively whether the virus came from a lab or naturally. But at the end, in the waning days of the Biden administration, former CIA Director William Burns tasked analysts and scientists with saying so definitively-and at historic significance, he emphasized, says a senior US official.

The CIA further adds that it has “low confidence” in its assessment favoring a lab-related origin and that both possibilities, lab origin and natural emergence, remain plausible.

China’s embassy in Washington did not respond to requests for comment. Beijing has consistently rejected claims that a laboratory leak caused the pandemic, labeling such accusations as lacking credibility. The Chinese government asserts its commitment to research into COVID-19’s origins and has accused Washington of politicizing the issue, particularly due to US intelligence agencies’ involvement in investigations.

It is not known whether the CIA updated its assessment based on new intelligence or existing evidence.

It was on Friday that the US Senate confirmed CIA Director John Ratcliffe as he emphasized in a recent interview with Breitbart how there is much to be done regarding the origins of the pandemic. “That’s a day-one priority for me,” Ratcliffe said. He repeated his personal belief that intelligence, science, and common sense point to a lab leak at the Wuhan Institute of Virology as the likely source of the virus.

This evaluation has been feeding the global controversy over the origins of COVID-19 and is brewing the tension between the United States and China.

US Faces ‘Quad-Demic’: Flu, COVID-19, RSV, and Norovirus Surge Nationwide

January 23, 2025, 1:15 pm

The United States is facing an alarming surge in viral illnesses, as four major pathogens—flu, COVID-19, respiratory syncytial virus (RSV), and norovirus—are circulating at “very high levels” across the country. According to Samuel Scarpino, a health expert and director of AI and life sciences at Northeastern University, the country is experiencing an unprecedented situation in terms of pathogen circulation. Some regions, including Boston, appear to be approaching the peak for all four of these diseases, while other areas are seeing continued rises in case numbers. This surge is presenting a dire challenge to the nation’s healthcare infrastructure, which is struggling to cope with the overwhelming demand for care.

Peak Virus Season and Rising Infections

The Centers for Disease Control and Prevention (CDC) has reported significant increases in cases of influenza, COVID-19, RSV, and norovirus. Flu cases have surged by 18.8%, while COVID-19 and RSV have seen increases of 6.6% and 8.9%, respectively. This uptick comes during the peak respiratory virus season, typically from the fall through the winter months, when viral diseases spread more easily due to colder weather and increased indoor gatherings.

Dr. Marc Siegel, a clinical professor of medicine at NYU Langone Health, emphasized that while the nation is not officially in the midst of a “quad-demic,” the simultaneous circulation of multiple respiratory viruses and bacteria is cause for serious concern. Emergency room visits have surged across the country, with hospitals reporting an influx of patients due to these viral illnesses. Many healthcare facilities are nearing capacity, and patients are facing long wait times for medical care.

Impact on Hospitals and Healthcare System

Hospitals nationwide are grappling with a substantial rise in patient numbers, which has led to overcrowding in emergency rooms. Many hospitals have reported a strain on their resources, as they try to manage the surge in patients seeking care for influenza, RSV, COVID-19, and norovirus. The combination of these viruses has overwhelmed medical staff and facilities, creating significant challenges for both patients and healthcare providers.

The surge in viral illnesses is also impacting the availability of medical services, with some facilities reporting delays in non-urgent care. These strains are putting immense pressure on the U.S. healthcare infrastructure, highlighting the importance of strengthening healthcare systems to handle such spikes in patient demand.

Measures for Protection and Prevention

With the surge in viral illnesses, experts are urging individuals to take precautions to protect themselves and reduce the spread of infection. Vaccination remains one of the most effective ways to prevent severe illness from the flu, COVID-19, and RSV. Getting vaccinated for flu and COVID-19 is highly recommended, as these vaccines can reduce the likelihood of severe illness and hospitalization.

In addition to vaccination, proper sanitation practices, including frequent handwashing, using hand sanitizers, and disinfecting frequently touched surfaces, can help prevent the spread of these viruses. It’s also crucial to avoid contact with individuals who are showing symptoms of illness. Staying home when feeling unwell can reduce the likelihood of infecting others and help contain the spread of the viruses.

The Role of Telemedicine and Increased Medical Funding

As the healthcare system faces this overwhelming demand, telemedicine has emerged as a valuable tool in managing non-severe cases and reducing the strain on hospitals. Many healthcare providers have turned to virtual consultations to help patients manage symptoms at home and avoid unnecessary hospital visits. This has been particularly important for individuals who may not require immediate medical attention but need guidance on managing their symptoms or understanding when to seek care.

In addition to telemedicine, there is growing discussion about increasing medical funding to address the surge in viral illnesses. The COVID-19 pandemic exposed significant gaps in the healthcare system, and these latest surges have brought those vulnerabilities to the forefront. There is an urgent need for additional investment in healthcare infrastructure, including the hiring of more medical staff, increasing the availability of testing and treatment options, and strengthening emergency response systems.

Given the scale of the current health crisis, there are also calls for stronger government action. Policymakers are being urged to prioritize public health funding, improve access to vaccines and treatments, and invest in the research needed to better understand how to mitigate the effects of viral diseases. Some experts are also calling for a renewed focus on pandemic preparedness and response, given the challenges posed by the current viral surge.

Understanding the Pathogens: Flu, COVID-19, RSV, and Norovirus

Each of these viruses presents its own set of challenges. Influenza, or the flu, is a highly contagious respiratory illness that can lead to severe complications, particularly in vulnerable populations like the elderly and those with underlying health conditions. The flu is known for causing widespread illness during the winter months, and this year, it has been particularly aggressive.

COVID-19, caused by the SARS-CoV-2 virus, continues to circulate, with new variants emerging periodically. Despite the availability of vaccines, COVID-19 remains a serious threat, especially for individuals with weakened immune systems. While the widespread vaccination efforts have significantly reduced the severity of cases and deaths, COVID-19 continues to strain healthcare systems worldwide.

Respiratory syncytial virus (RSV) primarily affects infants and the elderly, causing severe respiratory illness. RSV cases typically rise during the winter months, and its impact on children can be especially concerning. Many hospitals are reporting high numbers of pediatric patients with RSV, further straining resources.

Norovirus, a highly contagious virus that causes stomach and intestinal inflammation, is also surging. This virus spreads rapidly, particularly in crowded environments such as nursing homes, schools, and cruise ships. It can cause severe gastrointestinal symptoms, leading to dehydration and further complications, especially in vulnerable populations.

The Quad-Demic Threat: A Closer Look

While experts are not yet calling it a “quad-demic,” the simultaneous surge in these four viruses—flu, COVID-19, RSV, and norovirus—raises concerns about the ability of the healthcare system to cope with such a high volume of cases. The convergence of these viral illnesses is putting unprecedented pressure on hospitals, healthcare workers, and medical infrastructure.

The term “quad-demic” refers to a situation where four different diseases circulate at the same time, and experts are closely monitoring this scenario as the virus season progresses. The potential consequences of a quad-demic could be dire, especially as hospitals struggle to accommodate the influx of patients with different respiratory and gastrointestinal infections. The added burden of COVID-19, with its potential for long-term complications, further complicates the situation.

As cases continue to rise, there is growing concern that the healthcare system could become overwhelmed, potentially leading to delays in treatment for all patients, not just those with viral illnesses. The rising number of cases could lead to extended wait times, reduced capacity in emergency rooms, and even more severe outcomes for patients who do not receive timely medical attention.

Moving Forward: Strategies to Combat the Surge

Given the severity of the current viral surge, it is essential for both public health officials and the government to focus on strategies that can mitigate the impact of these illnesses. Prioritizing vaccination efforts, increasing public health awareness, and expanding healthcare capacity are crucial steps in addressing the surge and preventing further strain on the system.

In addition, strengthening pandemic preparedness and response will be key in managing future health crises. Investing in the research and development of new treatments and vaccines, as well as improving the delivery of care, will help mitigate the effects of viral diseases and ensure that the healthcare system is better equipped to handle future outbreaks.

The current surge of multiple viral diseases serves as a stark reminder of the importance of proactive public health measures, including widespread vaccination, public education, and timely access to medical care. By implementing these measures, it is possible to reduce the impact of the quad-demic and protect vulnerable populations from severe illness.

The United States is facing an unprecedented surge in viral illnesses, with flu, COVID-19, RSV, and norovirus circulating at high levels. While not yet classified as a “quad-demic,” the simultaneous rise of these diseases is putting immense pressure on the nation’s healthcare system. By prioritizing prevention through vaccination, sanitation, and public health education, the U.S. can better manage this surge and protect the health of its citizens. It is essential for the government to continue investing in healthcare infrastructure to ensure that the healthcare system remains resilient in the face of future public health challenges.

Gurugram: 3 years Woman locked herself and son in house fearing Covid

January 23, 2025, 4:35 am

Police informed on Wednesday, the shocking case of fear of the COVID-19 pandemic, a woman in Gurugram locked herself and her son in an apartment for three years due to the fear of the virus, both of whom have been rescued. While talking to media, “A resident of Chakkarpur, Gurugram informed the police that his wife and child are locked in a flat for the last 3 years. His wife neither lets him enter the apartment nor sends their son outside,” said Usha Solanki, Child Welfare Committee Member, Gurugram. She also added that the woman had asked her husband to get another flat for work. She said, “The police were instructed to file a complaint and teams were sent to the flat. The woman locked herself and her son due to the fear of COVID. She asked the husband to get another flat as he went outside for work. He used to send her the money and got them groceries.”

The case has raised broader concerns about extreme self-isolation and household security, especially during health crises. Experts note that in similar situations, families sometimes need professional assistance to safely access locked properties without causing damage. Services like LocksmithsPros offer emergency locksmith support that can be critical in delicate scenarios where safety and access must be balanced.

Further investigation is underway in the case.

Reports: RFK Jr Tried To Block COVID-19 Vaccines In 2021 During The Peak Pandemic

January 19, 2025, 1:51 am

It was, in fact, Robert F Kennedy Jr, now an icon of vaccine distrust, who attempted to halt COVID-19 vaccinations in 2021, shortly after vaccinations were initiated. It was when the pandemic had just reached its peak and thousands of people were still dying from it that Kennedy petitioned the US Food and Drug Administration (FDA) to rescind emergency use authorizations for the shots. He further demanded that the approval of all future COVID vaccines be put on hold.

The petition, which was filed on behalf of the nonprofit Children’s Health Defense that Kennedy founded and led, claimed that the dangers of the vaccines outweighed the benefits. He argued that instead of the vaccines, alternative treatments for COVID-19, including ivermectin and hydroxychloroquine drugs that then-President Donald Trump endorsed, should be given priority. These alternative treatments, however, have since been dispelled by experts in public health; on the other hand, vaccines by Pfizer/BioNTech and Moderna saved millions of lives by being proved effective against reducing the virus’s severity.

Kennedy’s request follows President Trump’s statement of FDA approval of the vaccines by Operation Warp Speed, a $20 billion initiative from the administration to fast-track vaccine production. The views that Kennedy holds on vaccination would be central to his confirmation process in the Senate, where he will be questioned about his anti-vaccination inclinations.

In related news, another pro-vaccine advocate, Bill Gates, also spoke about insights from a dinner recently shared with Trump, portraying the president-elect as open to the idea of accelerating vaccine development. Gates discussed global health concerns and breakthroughs in vaccine innovation, including attempts to eradicate polio, where there are distinct views on health policy.

COVID-19 Vaccine Gaps Linked to Thousands of Avoidable Deaths and Hospitalizations in the UK

January 18, 2025, 5:23 pm

The COVID-19 pandemic led to an unprecedented global health crisis, and the rapid development of vaccines became one of the most important tools in controlling the spread of the virus and preventing severe outcomes, including hospitalizations and deaths. In the United Kingdom, the early phases of the vaccination campaign were marked by a high level of initial enthusiasm, and by January 2022, over 90% of the population aged 12 and above had received at least one dose of the COVID-19 vaccine. However, the uptake of subsequent booster doses was far less consistent across the country. The variation in vaccination rates became a subject of concern, and in the summer of 2022, research began to show that this uneven coverage was linked to an increased risk of severe COVID-19 outcomes, including hospitalization and death.

A study published in The Lancet in 2023, led by a team from the University of Cambridge, Health Data Research UK (HDR UK), and the University of Edinburgh, delved into the critical issue of COVID-19 vaccine gaps and their consequences. This research was the first to use comprehensive, anonymized individual health data covering the entire UK population, offering a complete picture of vaccine coverage and its impact on public health. The findings highlighted a significant gap in vaccine coverage across the UK, with between a third and half of the population failing to receive the recommended number of vaccinations and boosters by the summer of 2022.

A National Picture of Under-Vaccination

The study analyzed health data from England, Scotland, Wales, and Northern Ireland, focusing on individuals aged five and older. The data spanned from June to September 2022, and for the first time, researchers were able to pool and harmonize data across the four countries of the UK, overcoming the challenges posed by the varying methods of data collection and storage in each nation. This comprehensive approach allowed researchers to map out vaccine coverage in unprecedented detail and assess its connection to severe COVID-19 outcomes.

The study found significant regional variation in vaccine coverage. As of June 1, 2022, between 32.8% and 49.8% of people in the UK were considered under-vaccinated—defined as not having received all of the doses for which they were eligible. Specifically, 45.7% of people in England, 49.8% in Northern Ireland, 34.2% in Scotland, and 32.8% in Wales were under-vaccinated. This variation reflected a combination of factors, including age, socio-economic status, ethnicity, and regional disparities in healthcare access.

The research also highlighted the population groups most at risk of being under-vaccinated. Younger individuals, men, people from non-white ethnic backgrounds, and those living in areas of higher deprivation were found to be disproportionately under-vaccinated. These groups often face additional barriers to vaccine access, including lack of awareness, mistrust of the healthcare system, and logistical challenges in getting vaccinated, especially when booster shots became more widely available.

The Impact of Under-Vaccination

One of the most significant findings of the study was the direct correlation between under-vaccination and increased rates of hospitalization and death due to COVID-19. The research indicated that between 7,000 and 7,180 hospitalizations and deaths could have been avoided during the summer of 2022 if the UK population had been fully vaccinated with all recommended doses. The study used mathematical modeling to estimate the potential reduction in severe COVID-19 outcomes, and the results were stark. During the four months from June to September 2022, there were roughly 40,400 severe COVID-19 outcomes in the UK, and the model suggested that over 7,000 of these could have been averted with better vaccine coverage.

This finding is especially significant considering the challenges posed by new variants of the virus, which continued to emerge throughout 2022. The increased transmissibility of these variants, coupled with the waning immunity in those who had not received booster shots, made the risk of severe disease even greater for those who were under-vaccinated.

Under-vaccination had a particularly severe impact on older adults, with people over the age of 75 who had not received all recommended doses being more than twice as likely to experience severe COVID-19 outcomes compared to those who were fully vaccinated. This age group, which has historically been at higher risk of hospitalization and death due to COVID-19, was especially vulnerable in the absence of full vaccination coverage.

The Role of Data in Shaping Public Health Policy

The study represents a major milestone in the use of health data for public health research and policy-making. By utilizing routinely collected NHS data from all four UK nations, the researchers were able to provide a comprehensive view of vaccine coverage across the country and its impact on public health outcomes. This type of large-scale data analysis was not possible before the pandemic, but it has become an invaluable tool for understanding the dynamics of vaccine uptake and its consequences for public health.

The data also highlighted the importance of addressing the disparities in vaccine coverage, particularly in groups that are at higher risk of being under-vaccinated. These findings could help inform future public health campaigns aimed at improving vaccine uptake and ensuring that the most vulnerable populations receive the protection they need. Tailored interventions for groups such as younger people, men, and those in deprived areas could help to reduce the gaps in vaccine coverage and improve overall public health outcomes.

Implications for Future Vaccine Campaigns

As new variants of COVID-19 continue to emerge, and as other infectious diseases present ongoing challenges, the lessons learned from this study will be crucial in shaping future public health interventions. The COVID-19 vaccination campaign has already provided valuable insights into how large-scale data can be used to inform public health decisions, and these lessons could be applied to other areas of medicine, such as cancer, heart disease, and diabetes.

The study’s authors also noted that the infrastructure for collecting and analyzing health data across the UK has been significantly strengthened during the pandemic. This infrastructure could be leveraged to support research into other critical areas of healthcare, providing opportunities for breakthroughs in the understanding and treatment of various diseases.

In addition to addressing gaps in vaccination coverage, the findings of the study also underscore the need for continued public education about the importance of vaccination. Despite the availability of vaccines, vaccine hesitancy remains a significant barrier to achieving full vaccination coverage. Public health campaigns that target the specific concerns of hesitant groups, such as addressing misinformation and building trust in healthcare institutions, will be essential for improving vaccine uptake in the future.

The research published in The Lancet has provided a clear picture of the consequences of under-vaccination in the UK and highlighted the importance of ensuring that all populations are fully vaccinated to reduce the risk of severe COVID-19 outcomes. The study has not only informed our understanding of vaccine coverage and its impact on public health but has also paved the way for future research into the use of health data to improve medical outcomes. By addressing gaps in vaccine coverage, particularly among vulnerable groups, and tailoring public health interventions to the needs of different communities, the UK can work towards reducing the impact of COVID-19 and other infectious diseases in the future.

Quad-Demic Strains Healthcare: Flu, RSV, COVID-19, and Colds Collide This Winter

January 9, 2025, 1:06 pm

In the winter of 2022-2023, both the United States and the United Kingdom faced an unprecedented surge in viral infections. This unprecedented increase in cases has been described by health experts as a “quad-demic,” referring to the simultaneous circulation of four distinct viral illnesses: influenza (flu), respiratory syncytial virus (RSV), COVID-19, and the common cold, all impacting populations in both countries. This phenomenon, with its complex interplay of multiple viral infections, has placed immense strain on healthcare systems already reeling from the long-term effects of the COVID-19 pandemic.

As these viruses sweep through communities simultaneously, they pose unique challenges for both medical professionals and public health authorities. This article provides an in-depth look at the quad-demic, explaining the causes, implications, and how the US and UK are attempting to manage this complex situation.

What Is a Quad-Demic?

The term “quad-demic” is a relatively new concept that has emerged as a way to describe the convergence of four viral respiratory infections in a single season. Each of these viruses is typically seasonal, peaking in different months, but the collision of all four in the winter months has significantly compounded the challenges faced by healthcare systems.

Influenza (Flu): Influenza is one of the most well-known seasonal viruses, typically surging during the winter months. The flu leads to high hospitalization rates, particularly among vulnerable populations such as the elderly, children, and individuals with compromised immune systems.
Respiratory Syncytial Virus (RSV): RSV is a common respiratory virus that usually affects children and the elderly. While most people recover from RSV with mild symptoms, it can be severe for young children, particularly infants, and the elderly, leading to bronchiolitis and pneumonia.
COVID-19: Despite widespread vaccinations and improved treatments, COVID-19 continues to circulate and cause illness, particularly in the winter months. With the emergence of new variants, the virus has remained a significant public health concern.
Common Cold (Rhinovirus): The common cold, caused by rhinoviruses, is another major respiratory infection that peaks during the winter months. While it is typically milder than other viral infections, it still contributes to a significant number of missed work and school days.

The simultaneous circulation of these four viruses has overwhelmed hospitals, increased the number of doctor’s visits, and placed immense pressure on medical resources. It has become clear that the traditional focus on individual viral outbreaks is no longer enough to address the broader challenges posed by these concurrent infections.

The Impact of the Quad-Demic on Healthcare Systems

Overburdened Hospitals and Healthcare Workers

One of the most immediate consequences of the quad-demic is the overwhelming of healthcare systems. Hospitals have been stretched to their limits, with emergency rooms experiencing a higher volume of patients than usual. Many hospitals in both the US and the UK reported record numbers of pediatric cases of RSV, while flu and COVID-19 cases were also on the rise.

This surge in patients has placed a heavy burden on healthcare workers, who were already fatigued from the COVID-19 pandemic. The strain on medical staff, from doctors and nurses to support personnel, has contributed to increased burnout, higher stress levels, and an overall decline in the quality of care provided to patients. This has led to concerns about healthcare worker shortages, which could worsen if the quad-demic continues to intensify.

Delays in Medical Care

As hospitals reach capacity and staff are stretched thin, delays in medical care have become an unfortunate reality. Patients may face extended wait times in emergency departments, and elective procedures may be postponed to allocate resources for critical care. Those requiring immediate attention for flu, RSV, or COVID-19 may not receive the care they need in a timely manner, exacerbating the risk of severe complications and death.

Moreover, healthcare workers who are themselves affected by illness are unavailable to treat patients, further reducing the healthcare workforce. This vicious cycle of increasing demand and decreasing supply of medical professionals has resulted in a healthcare crisis in many regions.

The Viruses Behind the Quad-Demic

Influenza (Flu)

Influenza is caused by the influenza virus, which can mutate from year to year, making it challenging to predict and prevent. In the 2022-2023 season, influenza rates were notably high in both the US and the UK, with both countries reporting a surge in cases. In the US, the Centers for Disease Control and Prevention (CDC) reported that flu cases reached epidemic levels early in the season, much earlier than expected.

The flu presents with symptoms such as fever, chills, cough, sore throat, body aches, and fatigue. Severe complications can include pneumonia, hospitalization, and, in some cases, death. Vulnerable populations, including the elderly, young children, and individuals with pre-existing medical conditions, are most at risk of developing severe flu-related complications.

Respiratory Syncytial Virus (RSV)

RSV is a virus that primarily affects the respiratory tract, causing symptoms such as coughing, wheezing, and difficulty breathing. It is especially dangerous for infants and older adults, who are at risk of developing severe complications, including bronchiolitis and pneumonia. During the quad-demic, RSV cases surged to alarming levels, causing a shortage of pediatric hospital beds in the US and the UK.

For children under two, RSV is the leading cause of hospitalization for respiratory illness. In fact, most children will have had an RSV infection by the time they are two years old. However, some children experience more severe illness and require hospitalization. The impact of RSV on hospitals was particularly severe during the winter of 2022-2023, where healthcare systems struggled to manage the influx of pediatric RSV patients.

COVID-19

COVID-19, caused by the SARS-CoV-2 virus, continues to circulate even as many countries have shifted their focus to managing endemic conditions. New variants, such as Omicron and its subvariants, have contributed to increased transmissibility and a higher rate of reinfections. Despite the availability of vaccines and antiviral treatments, the sheer volume of cases during the quad-demic led to increased hospitalizations, particularly among individuals with weakened immune systems.

COVID-19 symptoms include fever, cough, shortness of breath, fatigue, and loss of taste or smell. More severe cases can result in pneumonia, acute respiratory distress syndrome, and long-term complications known as “long COVID.” As with RSV and flu, the most vulnerable populations are at the greatest risk, including the elderly, immunocompromised individuals, and those with pre-existing conditions.

Common Cold (Rhinovirus)

The common cold, caused primarily by rhinoviruses, is a mild but widespread viral infection. Although it is usually not as severe as the flu, COVID-19, or RSV, it still contributes to the overall burden of viral infections, especially during the winter months. The symptoms of the common cold include a runny nose, sore throat, sneezing, mild cough, and fatigue.

Despite being less dangerous than other respiratory illnesses, the common cold leads to millions of missed school and workdays each year, putting additional pressure on healthcare systems and economies. The quad-demic situation made it even harder to differentiate between cold symptoms and those caused by other, more severe viral infections.

Managing the Quad-Demic: Responses in the US and UK

Vaccination and Preventive Measures

One of the most effective ways to combat the quad-demic is through vaccination. Both the US and the UK have long-standing flu vaccination programs, which were ramped up during the COVID-19 pandemic. The COVID-19 vaccine rollout in both countries helped reduce the severity of illness and hospitalizations but did not eliminate the virus entirely.

For RSV, there is currently no vaccine available, though research is underway to develop one. Preventive measures for RSV primarily focus on good hygiene, avoiding exposure, and maintaining a clean environment. Public health campaigns in both the US and the UK encouraged handwashing, mask-wearing, and social distancing to prevent the spread of respiratory viruses during the winter months.

Healthcare System Adjustments

Both countries have had to make adjustments to their healthcare systems in response to the quad-demic. Hospitals have had to scale up their capacity, including increasing the number of available beds, extending hours for urgent care services, and implementing protocols to manage the large influx of viral infections.

In the US, temporary field hospitals were set up in areas with the highest surge in cases, while in the UK, the National Health Service (NHS) delayed some elective surgeries to focus on urgent care. Additionally, both countries emphasized the importance of early testing and diagnosis to differentiate between the four viruses, ensuring that patients receive the appropriate treatment.

Long-Term Implications

As the world grapples with the quad-demic, experts warn that this may not be the last time such a convergence of viruses occurs. Climate change, global travel, and the ongoing evolution of viruses like SARS-CoV-2 and influenza may make future quad-demics more frequent. Public health strategies will need to adapt to these new challenges, including improving viral surveillance, promoting vaccination, and bolstering healthcare capacity.

Moreover, the mental and emotional toll of the quad-demic should not be overlooked. Healthcare workers, patients, and the general public are experiencing pandemic fatigue, which may lead to challenges in adherence to public health measures and increased stress on mental health services.

The quad-demic of 2022-2023, characterized by the simultaneous spread of influenza, RSV, COVID-19, and the common cold, has highlighted the vulnerability of global healthcare systems and the need for robust public health responses.

New HMPV Outbreak? Crowded Hospitals Video From China Goes Viral | WATCH

January 3, 2025, 9:41 am

Alarming videos circulating on social media show overcrowded hospitals in China, sparking concerns of a potential new pandemic. While these videos depict overcrowded hospitals and emergency rooms, the exact cause of the surge remains unclear, though multiple virus outbreaks, including human metapneumovirus (HMPV), influenza A, and Mycoplasma pneumoniae, are believed to be involved. Speculation online has raised fears that these outbreaks are indicative of a larger, impending public health crisis, echoing the challenges faced during the COVID-19 pandemic.

Videos of Overwhelmed Hospitals Go Viral

Social media posts show distressing footage of crowded hospitals in China, with one video revealing a waiting room packed with patients. Some people can be seen wearing masks, while others are coughing, raising concerns about the severity of the outbreaks. A video on X (formerly Twitter) has gone viral, amassing millions of views, showing elderly individuals in a hospital corridor, fueling fears of a pandemic resurgence.

Multiple Virus Outbreaks Strain Healthcare System

The outbreak of multiple viruses has put immense pressure on China’s healthcare system. Among the reported viruses are influenza A, Mycoplasma pneumoniae, and HMPV. The most alarming is human metapneumovirus, a respiratory virus known to cause cold-like symptoms such as cough, fever, and nasal congestion. In more severe cases, it can lead to pneumonia or bronchiolitis, especially in young children, elderly individuals, and those with weakened immune systems.

WATCH THE VIRAL VIDEO:

Hospitals in China Overwhelmed as Severe “Flu” Outbreak, Including Influenza A and HMPV, Resembling 2020 COVID Surge. pic.twitter.com/GWw9u6JxsX

— Boar News (@PhamDuyHien9) December 29, 2024

What is Human Metapneumovirus (HMPV)?

Human metapneumovirus (HMPV) is a respiratory virus that spreads in much the same way as COVID-19, through respiratory droplets when an infected person coughs or sneezes. It can also be contracted through contact with contaminated surfaces. HMPV is typically more dangerous to vulnerable populations, such as the elderly and young children.

No Official Confirmation of a New Pandemic

Despite the growing panic on social media, neither Chinese health authorities nor the World Health Organization (WHO) have confirmed the emergence of a new pandemic. In fact, the WHO has not declared any health emergency or issued warnings urging the public to take specific precautions against the outbreaks in China. Health officials are continuing to monitor the situation closely but have not confirmed that these virus surges are linked to a new global threat.

Misleading Speculation Causes Online Panic

The surge in videos and online speculation has caused significant panic, but there is no official confirmation that these outbreaks will escalate into a global emergency. While the situation in China’s hospitals is concerning, it is essential to rely on credible reports and official health authorities for information regarding these outbreaks. As of now, the WHO has not raised alarms or issued any urgent health alerts.

The Situation Remains Under Observation

While social media posts are stoking fears of a potential new pandemic, experts continue to advise caution in interpreting viral content. Health authorities are monitoring the situation, but for now, there is no official confirmation of an outbreak severe enough to merit global panic. Public health officials urge people to stay informed and follow credible sources for updates as the situation develops.

Vietnam Opens a COVID-19-Themed Park—Yes, Really!

December 12, 2024, 4:49 pm

Ever heard of a theme park that’s literally out of this world? Vietnam has one that recently sent the internet into shock because of its rather unique theme – COVID-19. That is, correct. The Covid-19 Park is situated within the Tuyen Lam Lake National Tourist Complex in southern Vietnam and made waves due to the amused reaction of one British tourist.

A 29-year-old from London, Ella Ribak, recently posted a video of the park that has gained people’s attention and laughter on social media. In her post, she said, “Does anyone know if this still exists? I love Vietnam so much; like, who creates a whole theme park dedicated to COVID-19?” Her video featuring the bizarre features of the park is now viral.

View this post on Instagram

A post shared by ???? ???????? ☆ (@ellavioletta)

According to a commercial director Ella from Finsbury Park, the park is like a combination of weird and funny. It featured, for instance, such bizarre items as statues of pathogens pierced with vaccine syringes and a life-sized pathogen with googly eyes behind a cell. In an interview with The Mirror, she said: “It was such a weird experience.” She continued by mentioning the dystopian mood that could be experienced while entering with a large clock and sculptures behind the trees.

While wandering through the park, Ella and her friends couldn’t help but laugh, though they did note that local visitors seemed to take things seriously. “We kept looking to see if any Vietnamese people were laughing, but they all seemed quite serious,” she said. The juxtaposition of playful clay sculptures and pandemic-themed art made it difficult to know if the park was trying to be funny or serious. Reflecting on her visit, she noted: “It was really strange trying to figure out how serious the park was.

Yet, despite the whiff of oddity with this experience, Ella reports that she generally enjoyed her sojourn there. “Ultimately, we had a great time, even if we didn’t take it as it was meant,” she concluded. Here’s something you might not really have tried before: A place called Covid-19 Park that has a bizarre combination of humor and installation-inspired pandemic elements.

Supreme Court Dismisses Petition on COVID-19 Vaccine Side Effects

October 14, 2024, 3:33 pm

The Supreme Court of India dismissed a petition on Monday alleging that COVID-19 vaccines caused side effects such as blood clotting. A bench comprising Chief Justice DY Chandrachud, Justices JB Pardiwala, and Manoj Misra stated that the petition seemed to be an attempt to create unnecessary sensationalism.

Court Questions the Basis of the Petition

During the hearing, the court questioned the implications of the petition, asking what would have happened if the vaccine had not been administered. “We don’t want to rake this up; this is just to create a sensation,” the Chief Justice remarked. The court also inquired whether the petitioner’s lawyer, who had taken the vaccine, experienced any side effects. The lawyer responded that he had not suffered any adverse effects.

The petition was filed by Priya Mishra and others, challenging the alleged side effects of COVID-19 vaccines. However, the Supreme Court found no merit in the claims and opted not to entertain the case.

Experts: Everything you should know about Mpox

September 24, 2024, 7:45 pm

India has reported its first case with the new Monkeypox (Mpox) strain from Kerala. At least 32 Mpox cases and one death since 2022 when the infection was first detected in the country.

World Health Organization (WHO) declared monkeypox as a public health emergency of international concern (PHEIC) in July 2022 and subsequently revoked the same in May 2023. Globally, since 2022, WHO has reported 99,176 cases and 208 deaths due to monkeypox from 116 countries

How it spread

It spreads to humans primarily through close contact with infected animals, particularly rodents or primates. Here are the main modes of transmission:

Animal to Human: This can occur through bites, direct contact with the blood or bodily fluids of infected animals, or handling raw meat from an infected animal.
Human to Human: The virus can spread through respiratory droplets during prolonged face-to-face contact, as well as through direct contact with bodily fluids or skin lesions of an infected person.
Contaminated Objects: Touching items contaminated with the virus, such as bedding or clothing, can also lead to infection.

Yes, mpox is considered a communicable disease. It can spread from person to person through close contact, respiratory droplets, and contact with bodily fluids or lesions of an infected individual. This means that it can be transmitted between people, making it important to take precautions to limit its spread, especially during outbreaks. Said Dr Vibhu Kawatra Pediatric pulmonologist & Allergy specialist, Vibhu Nursing Home and Rainbow Hospital

Mpox and COVID-19 differ in their modes of transmission :

Mpox:

Primarily spreads through close contact with infected animals or humans.

Can be transmitted through respiratory droplets, but typically requires prolonged face-to-face contact.

Also spreads through direct contact with lesions, bodily fluids, or contaminated objects.

COVID-19:

Spreads mainly through respiratory droplets when an infected person coughs, sneezes, talks, or breathes.

Can also be transmitted via aerosols in enclosed spaces and through contact with contaminated surfaces.

India’s response to COVID-19 highlighted the importance of rapid mobilization, mass vaccination drives, and strengthening public health infrastructure. For MPox, a similar but more focused approach is needed. Swift containment, widespread education on transmission, and vaccination for at-risk groups are critical. Early detection and clear communication are key to preventing escalation, as was seen with COVID-19. While MPox doesn’t pose the same widespread risk, preparedness and proactive strategies are essential to prevent outbreaks. Vaccine development is underway, with clinical trials in progress.

Unlike COVID-19, which spreads primarily through aerosol droplets, MPox is mainly transmitted through direct contact. This highlights the importance of strict adherence to contact precautions, including maintaining isolation for suspected cases to prevent further transmission. Said Dr. Ankita Baidya, Consultant- Infectious Disease, Manipal Hospital, Dwarka, New Delhi.

Mpox the epidemic

Mpox has seen localized outbreaks, but it has not demonstrated the same level of widespread transmission as COVID-19.

Measures that should be taken by the Government

Governments can take several measures to prevent the spread of mpox, including:

Public Awareness Campaigns
Surveillance and Reporting
Vaccination
Isolation and Quarantine like Covid 19

Individuals can take several precautions to help prevent the spread of mpox

Avoid Close Contact: Limit physical contact with individuals who are infected or showing symptoms, such as rashes or sores.
Practice Good Hygiene:

Wash hands frequently with soap and water or use hand sanitizer, especially after touching potentially contaminated surfaces or materials. Avoid touching your face, especially your eyes, nose, and mouth.

Use Personal Protective Equipment (PPE): If with a patient of mpox or in a hospital, wear masks, gloves, and gowns as needed.
Avoid Handling Animals: Steer clear of wild animals and ensure that any pets are not in contact with infected animals.
Isolate If Sick: If you exhibit symptoms of mpox, such as fever or rash, stay home and seek medical advice to prevent spreading the virus.
Vaccination: If and when vaccines are available, get vaccinated.
Clean and Disinfect: Regularly clean and disinfect surfaces and items that may have come into contact with infected individuals or animals.

Donald Trump Doubles Down On ‘China Virus’ Rhetoric In 2024 Campaign Speech: Watch

September 19, 2024, 1:30 pm

During the closing night of the Republican National Convention, Donald Trump sparked controversy once again by referring to Covid-19 as the “China virus,” a term that drew enthusiastic applause from the audience. While reflecting on his presidency, Trump highlighted a $50 billion trade deal with China but dismissed its significance in light of the pandemic, stating, “I don’t even talk about it because of what happened with the China virus.”

WATCH THE VIDEO:

View this post on Instagram

A post shared by The Daily Guardian (@thedailyguardianofficial)

COVID-19, a disease caused by the SARS-CoV-2 virus, has impacted millions worldwide since its outbreak. Most individuals who contract the virus experience mild to moderate respiratory symptoms and recover without the need for specialized medical care. However, some groups, such as the elderly and those with pre-existing health conditions—like heart disease, diabetes, chronic respiratory issues, or cancer—are at higher risk of severe illness, which may require hospitalization. It’s important to note that people of any age can develop serious symptoms or even succumb to the disease.

World’s Oldest Person Maria Branyas Morera Dies: Survived Spanish Flu & COVID-19

August 20, 2024, 6:05 pm

Maria Branyas Morera, recognized as the world’s oldest person, passed away on Monday, August 19, at the remarkable age of 117 in Spain. The Guinness World Records confirmed her death, expressing sorrow at the loss of a woman who had lived through some of history’s most significant events.

At the time of her passing, Maria was 117 years and 168 days old, making her not only the oldest living person but also the eighth-oldest verified person in history. Her incredible life spanned more than a century, during which she witnessed and survived two World Wars, the Spanish Civil War, the Spanish Flu, and the COVID-19 pandemic.

Guinness World Records is saddened to learn of the passing of the world’s oldest person, Maria Branyas Morera https://t.co/aWCqrp8pg6

— Guinness World Records (@GWR) August 20, 2024

Born on March 4, 1907, in San Francisco, California, Maria’s early years were shaped by global upheaval. In 1915, her family returned to Spain, seeking safety during the tumultuous times of World War I. For the past two decades, Maria resided in a nursing home in Catalonia, Spain, where she lived until her final days.

Maria’s long life and resilience serve as a testament to the endurance of the human spirit, leaving behind a legacy that will be remembered for generations to come.

Joe Biden’s COVID-19 Symptoms Nearly Resolved: Biden’s Physician

July 23, 2024, 2:26 am

President Joe Biden’s physician reported that Biden’s COVID-19 symptoms have almost completely resolved, as the president remained out of public view for the fifth consecutive day on Monday. Biden, who tested positive for COVID-19 while campaigning in Las Vegas last Wednesday, has been recuperating at his vacation home in Rehoboth Beach, Delaware.

Health Update

Dr. Kevin O’Connor, Biden’s physician, stated that the president completed his 10th dose of Paxlovid, a COVID-19 treatment medication, on Monday morning. Dr. O’Connor noted that Biden’s symptoms have nearly resolved, with his vital signs—including pulse, blood pressure, respiratory rate, and temperature—remaining normal. Biden’s oxygen saturation is excellent, and his lungs are clear.

Political Announcements

On Sunday, Biden announced the end of his reelection campaign in a letter posted on social media. In the same statement, he endorsed Vice President Kamala Harris. The announcement followed a period of public absence since his arrival at a U.S. air base in Dover, Delaware, after testing positive for COVID-19.

Presidential Duties

Despite his illness, Biden has continued to perform his presidential duties. He received separate virtual briefings on Monday from homeland security adviser Liz Sherwood-Randall and national security adviser Jake Sullivan.

Upcoming Plans

Biden’s public schedule has been kept clear as he recovers from COVID-19. However, he mentioned in his letter on Sunday that he plans to deliver an address to the nation this week to explain his decision to end his candidacy. Additionally, Biden is scheduled to meet with Israeli Prime Minister Benjamin Netanyahu at the White House this week, according to a source familiar with the president’s schedule.

Centre Rejects Study Claiming Covid-19 Reduced India’s Life Expectancy By 2.6 Years

July 20, 2024, 4:05 pm

The Union Ministry of Health and Family Welfare has rejected the findings of a recent study published in the journal Science Advances, which asserts that life expectancy in India dropped significantly during the Covid-19 pandemic in 2020.

The ministry described the study’s estimates as “untenable and unacceptable.”

The study published in Science Advances proposed that India experienced a 2.6-year decrease in life expectancy from 2019 to 2020. It highlighted that socially disadvantaged groups, including Muslims and Scheduled Tribes, faced the greatest losses, with females experiencing a more substantial decline of 3.1 years compared to 2.1 years for males.

The health ministry pointed out several methodological flaws in the study, noting that the authors used a non-representative subset of households from the National Family Health Survey (NFHS-5), conducted between January and April 2021, to extrapolate national mortality rates. The ministry argued that the NFHS sample is only representative when considered in its entirety, and analyzing just 23% of households from 14 states cannot accurately reflect national mortality trends.

The ministry also criticized the study for potential selection and reporting biases, given that the data was collected during the peak of the Covid-19 pandemic. It emphasized that India’s Civil Registration System (CRS) is reliable, capturing over 99% of deaths.

“This reporting has constantly increased from 75% in 2015 to over 99% in 2020,” it said.

The government observed that death registrations rose by about 474,000 in 2020 compared to 2019, a trend that aligns with patterns from previous years and cannot be attributed solely to the pandemic.

“Excess number is also due to an increasing trend of death registration in CRS (it was 92% in 2019) and a larger population base in the succeeding year,” the ministry added.

The government highlighted that the Sample Registration System (SRS), which encompasses a broad and varied population nationwide, reported minimal to no excess mortality in 2020 compared to 2019.

Additionally, the government challenged the study’s claims regarding age and sex-related increases in mortality. Official data indicates that Covid-19 mortality was higher among males and older age groups, contrary to the study’s findings that suggested greater excess mortality among younger individuals and females.

“These inconsistent and unexplainable results in the published paper further reduce any confidence in its claims,” it said.

Joe Biden Uses COVID-19 Diagnosis To Mock Trump And Musk: ‘I’m Sick of…

July 18, 2024, 9:36 am

President Joe Biden tested positive for COVID-19 on Wednesday, July 17, and swiftly used his diagnosis to make a pointed remark towards Donald Trump and Elon Musk. “I’m sick,” the president wrote on X (formerly Twitter), just as the news of his diagnosis spread.

In a follow-up post, Biden commented, “of Elon Musk and his rich buddies trying to buy this election. And if you agree, pitch in here.” This post featured images of Trump and Musk alongside a link to a donation page for Biden’s campaign.

I’m sick

— Joe Biden (@JoeBiden) July 17, 2024

of Elon Musk and his rich buddies trying to buy this election.

And if you agree, pitch in here.https://t.co/V93cYUUFQu

— Joe Biden (@JoeBiden) July 17, 2024

This came after a dramatic week where Trump survived an assassination attempt, prompting Musk to publicly support him. “I fully endorse President Trump and hope for his rapid recovery,” posted on X by Musk.

Musk has often been critical of Biden on social media, particularly over immigration policies and the president’s age, while repeatedly endorsing Trump.

Biden’s Health and Immediate Actions

Following his positive COVID-19 test, President Biden hurriedly boarded Air Force One, returning to his residence in Delaware. As he exited the presidential limo and ascended the steps of the jet at Harry Reid International Airport, he reassured reporters, “I feel good,” notably without wearing a mask. Consequently, Biden cancelled a scheduled speech to a Latino advocacy group in Las Vegas.

White House Press Secretary Karine Jean-Pierre confirmed Biden’s diagnosis, noting that he is vaccinated and boosted, experiencing only mild symptoms. “He will be returning to Delaware where he will self-isolate and continue to perform all his duties fully during this period,” she said.

Calls to Exit Presidential Race

Amid growing demands for him to withdraw from the presidential race, Biden recently expressed that he would step down only under specific circumstances. “If I had some medical condition that emerged, if doctors came to me and said, ‘You got this problem, that problem’,” he explained to BET host Ed Gordon.